Unveiling a novel <italic>GJB2</italic> dominant K22T mutation in a Chinese family with hearing loss
Acta Biochimica et Biophysica Sinica · 2024
DOI: 10.3724/abbs.2024064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2024. Verfasst von Haiting Ji und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of the Affiliated Eye and ENT Hospital, State Key Laboratory of Medical Neurobiology, ENT Institute and Otorhinolaryngology, Fudan Univers…. Hauptthemen laut MEDLINE: Connexin 26, Hearing Loss. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Hearing loss constitutes one of the most prevalent conditions within the field of otolaryngology. Recent investigations have revealed that mutations in deafness-associated genes, including point mutations and variations in DNA sequences, can cause hearing impairments. With the ethology of deafness remaining unclear for a substantial portion of the affected population, further screenings for pathogenic mutations are imperative to unveil the underlying mechanisms. On this study, by using next-generation sequencing, we examine 129 commonly implicated deafness-related genes in a Chinese family with hearing loss, revealing a novel heterozygous dominant mutation in the GJB2 gene (GJB2: c.65T>G: p. Lys22Thr). This mutation consistently occurs in affected family members but is not detected in unaffected individuals, strongly suggesting its causative role in hearing loss. Structural analysis indicates potential disruption to the Cx26 gap junction channel's hydrogen bond and electrostatic interactions, aligning with predictions from the PolyPhen and SIFT algorithms. In conclusion, our study provides conclusive evidence that the identified heterozygous GJB2 mutation (GJB2: c.65T>G: p. Lys22Thr), specifically the K22T alteration, is the primary determinant of the family's deafness. This contribution enhances our understanding of the interplay between common deafness-associated genes and hearing loss, offering valuable insights for diagnostic guidance and the formulation of therapeutic strategies for this condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of the Affiliated Eye and ENT Hospital, State Key Laboratory of Medical Neurobiology, ENT Institute and Otorhinolaryngology, Fudan University, Shanghai 200031, China.
- NHC Key Laboratory of Hearing Medicine, Fudan University, Shanghai 200031, China.
- Shanghai Engineering Research Centre of Cochlear Implant, Shanghai 200031, China.
- ENT Institute and Otorhinolaryngology Department of Eye & ENT Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200031, China.
- Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
Zitieren
APA
Ji, H., Shu, Y., & Li, H. (2024). Unveiling a novel GJB2 dominant K22T mutation in a Chinese family with hearing loss. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2024064
Vancouver
Ji H, Shu Y, Li H. Unveiling a novel GJB2 dominant K22T mutation in a Chinese family with hearing loss. Acta Biochimica et Biophysica Sinica. 2024. doi:10.3724/abbs.2024064
BibTeX
@article{Ji2024,
author = {Ji, Haiting and Shu, Yilai and Li, Huawei},
title = {Unveiling a novel GJB2 dominant K22T mutation in a Chinese family with hearing loss},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2024},
doi = {10.3724/abbs.2024064}
}
EUVIMED